GLYCOMIMETICS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Glycomimetics Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • Glycomimetics Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $161M, a 7.59% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $161M +$11.4M +7.59% Dec 31, 2023 10-K 2024-03-27
Q4 2022 $150M +$13.4M +9.78% Dec 31, 2022 10-K 2024-03-27
Q4 2021 $137M +$21.6M +18.8% Dec 31, 2021 10-K 2023-03-29
Q4 2020 $115M +$19.2M +20% Dec 31, 2020 10-K 2022-03-03
Q4 2019 $95.9M +$21M +28% Dec 31, 2019 10-K 2021-03-02
Q4 2018 $74.9M +$18.5M +32.9% Dec 31, 2018 10-K 2020-02-28
Q4 2017 $56.4M +$1.69M +3.09% Dec 31, 2017 10-K 2019-03-06
Q4 2016 $54.7M +$15.2M +38.6% Dec 31, 2016 10-K 2018-03-06
Q4 2015 $39.4M +$6.78M +20.8% Dec 31, 2015 10-K 2017-03-01
Q4 2014 $32.7M +$6.2M +23.4% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $26.5M Dec 31, 2013 10-K 2015-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.